{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:10:26Z","timestamp":1790662226641,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015015","name":"Government of South Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.jaip.2021.03.005","type":"journal-article","created":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T17:38:49Z","timestamp":1616089129000},"page":"2235-2242","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"title":["The Genetic Basis and Clinical Impact of Hereditary Alpha-Tryptasemia"],"prefix":"10.1016","volume":"9","author":[{"given":"Kathleen T.","family":"Luskin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew A.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan J.","family":"Lyons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2021.03.005_bib1","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.jaci.2019.08.023","article-title":"AAAAI Mast Cell Disorders Committee Work Group Report: mast cell activation syndrome (MCAS) diagnosis and management","volume":"144","author":"Weiler","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.03.005_bib2","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.iac.2018.04.003","article-title":"Hereditary alpha tryptasemia: genotyping and associated clinical features","volume":"38","author":"Lyons","year":"2018","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2021.03.005_bib3","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.jaci.2013.11.039","article-title":"Mendelian inheritance of elevated serum tryptase associated with atopy and connective tissue abnormalities","volume":"133","author":"Lyons","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.03.005_bib4","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.jaci.2014.06.007","article-title":"Familial hypertryptasemia with associated mast cell activation syndrome","volume":"134","author":"Sabato","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.03.005_bib5","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1038\/ng.3696","article-title":"Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number","volume":"48","author":"Lyons","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaip.2021.03.005_bib6","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1515\/CCLM.2010.124","article-title":"Factors influencing serum total tryptase concentrations in a general adult population","volume":"48","author":"Gonzalez-Quintela","year":"2010","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jaip.2021.03.005_bib7","first-page":"282","article-title":"Serum tryptase levels and markers of renal dysfunction in a population with chronic kidney disease","volume":"23","author":"Sirvent","year":"2010","journal-title":"J\u00a0Nephrol"},{"key":"10.1016\/j.jaip.2021.03.005_bib8","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1016\/j.jaip.2020.05.057","article-title":"Hereditary alpha-tryptasemia: UK prevalence and variability in disease expression","volume":"8","author":"Robey","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.03.005_bib9","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jaci.2020.06.035","article-title":"Heritable risk for severe anaphylaxis associated with increased \u03b1-tryptase-encoding germline copy number at TPSAB1","volume":"147","author":"Lyons","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.03.005_bib10","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1182\/blood.2020006157","article-title":"Hereditary alpha tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis","volume":"137","author":"Greiner","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2021.03.005_bib11","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.aller.2014.05.002","article-title":"Clinical characteristics and risk profile of patients with elevated baseline serum tryptase","volume":"42","author":"Fellinger","year":"2014","journal-title":"Allergol Immunopathol"},{"key":"10.1016\/j.jaip.2021.03.005_bib12","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.jaci.2006.02.026","article-title":"Tryptase genetics and anaphylaxis","volume":"117","author":"Caughey","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.03.005_bib13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000327535","article-title":"Determinants of serum tryptase in a general population: the relationship of serum tryptase to obesity and asthma","volume":"157","author":"Fenger","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2021.03.005_bib14","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/j.1365-2362.2009.02184.x","article-title":"Elevated tryptase levels selectively cluster in myeloid neoplasms: a novel diagnostic approach and screen marker in clinical haematology","volume":"39","author":"Sperr","year":"2009","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jaip.2021.03.005_bib15","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jaci.2004.04.008","article-title":"Effect of sex and haplotype on plasma tryptase levels in healthy adults","volume":"114","author":"Min","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.03.005_bib16","doi-asserted-by":"crossref","first-page":"354","DOI":"10.2340\/00015555-1486","article-title":"The utility of serum tryptase as a marker in chronic spontaneous urticaria","volume":"93","author":"Siles","year":"2013","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaip.2021.03.005_bib17","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1111\/j.1365-2222.2010.03582.x","article-title":"Serum total tryptase levels are increased in patients with active chronic urticaria","volume":"40","author":"Ferrer","year":"2010","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2021.03.005_bib18","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.jaci.2019.05.007","article-title":"GATA-2-deficient mast cells limit IgE-mediated immediate hypersensitivity reactions in human subjects","volume":"144","author":"Desai","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"Suppl 1","key":"10.1016\/j.jaip.2021.03.005_bib19","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000312134","article-title":"FIP1L1\/PDGFR alpha-associated systemic mastocytosis","volume":"152","author":"Yamada","year":"2010","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2021.03.005_bib20","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1182\/blood-2003-01-0006","article-title":"Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness","volume":"101","author":"Klion","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2021.03.005_bib21","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.jaci.2009.09.022","article-title":"Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy","volume":"124","author":"Ogbogu","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.03.005_bib22","doi-asserted-by":"crossref","first-page":"71","DOI":"10.5045\/br.2017.52.1.71","article-title":"A\u00a0case of lymphocytic variant hypereosinophilic syndrome with sub-diagnostic systemic mastocytosis","volume":"52","author":"Jain","year":"2017","journal-title":"Blood Res"},{"key":"10.1016\/j.jaip.2021.03.005_bib23","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1086\/344318","article-title":"Association of transient dermal mastocytosis and elevated plasma tryptase levels with development of adverse reactions after treatment of onchocerciasis with ivermectin","volume":"186","author":"Cooper","year":"2002","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jaip.2021.03.005_bib24","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3389\/fimmu.2018.00207","article-title":"Elevated systemic levels of eosinophil, neutrophil, and mast cell granular proteins in strongyloides stercoralis infection that diminish following treatment","volume":"9","author":"Rajamanickam","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2021.03.005_bib25","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jaip.2017.08.039","article-title":"Persistent tryptase elevation in a patient with Gaucher disease","volume":"6","author":"Schussler","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.03.005_bib26","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.iac.2020.06.007","article-title":"Targeting mast cells with biologics","volume":"40","author":"Lyons","year":"2020","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2021.03.005_bib27","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000059404","article-title":"Serum tryptase levels in patients with mastocytosis: correlation with mast cell burden and implication for defining the category of disease","volume":"128","author":"Sperr","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2021.03.005_bib28","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1056\/NEJM198706253162603","article-title":"Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis","volume":"316","author":"Schwartz","year":"1987","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2021.03.005_bib29","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1084\/jem.183.6.2681","article-title":"Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in\u00a0vivo","volume":"183","author":"Costa","year":"1996","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaip.2021.03.005_bib30","first-page":"65","article-title":"Basal serum tryptase level correlates with severity of hymenoptera sting and age","volume":"17","author":"Kucharewicz","year":"2007","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2021.03.005_bib31","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.jaci.2009.07.026","article-title":"Human subjects are protected from mast cell tryptase deficiency despite frequent inheritance of loss-of-function mutations","volume":"124","author":"Trivedi","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.03.005_bib32","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/gim.2017.136","article-title":"A\u00a0common haplotype containing functional CACNA1H variants is frequently coinherited with increased TPSAB1 copy number","volume":"20","author":"Lyons","year":"2018","journal-title":"Genet Med"},{"key":"10.1016\/j.jaip.2021.03.005_bib33","doi-asserted-by":"crossref","first-page":"829068","DOI":"10.1155\/2014\/829068","article-title":"Evaluation on potential contributions of protease activated receptors related mediators in allergic inflammation","volume":"2014","author":"Zhang","year":"2014","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.jaip.2021.03.005_bib34","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1084\/jem.20170910","article-title":"The transcriptional program, functional heterogeneity, and clinical targeting of mast cells","volume":"214","author":"Cildir","year":"2017","journal-title":"J\u00a0Exp Med"},{"issue":"Pt 2","key":"10.1016\/j.jaip.2021.03.005_bib35","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S0091-6749(05)80222-2","article-title":"Tryptase, a mediator of human mast cells","volume":"86","author":"Schwartz","year":"1990","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.03.005_bib36","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1084\/jem.20191169","article-title":"When alpha meets beta, mast cells get hyper","volume":"216","author":"Ong","year":"2019","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaip.2021.03.005_bib37","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jaci.2016.11.044","article-title":"Tryptase-catalyzed core histone truncation: a novel epigenetic regulatory mechanism in mast cells","volume":"140","author":"Melo","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.03.005_bib38","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cell.2019.09.009","article-title":"An allosteric anti-tryptase antibody for the treatment of mast cell-mediated severe asthma","volume":"179","author":"Maun","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.jaip.2021.03.005_bib39","doi-asserted-by":"crossref","first-page":"19670","DOI":"10.1074\/jbc.274.28.19670","article-title":"Human tryptases alpha and beta\/II are functionally distinct due, in part, to a single amino acid difference in one of the surface loops that forms the substrate-binding cleft","volume":"274","author":"Huang","year":"1999","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jaip.2021.03.005_bib40","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.pupt.2004.09.032","article-title":"Inhibitors of mast cell tryptase beta as therapeutics for the treatment of asthma and inflammatory disorders","volume":"18","author":"Cairns","year":"2005","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.jaip.2021.03.005_bib41","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0022-2836(02)00625-3","article-title":"The crystal structure of human alpha1-tryptase reveals a blocked substrate-binding region","volume":"321","author":"Marquardt","year":"2002","journal-title":"J\u00a0Mol Biol"},{"key":"10.1016\/j.jaip.2021.03.005_bib42","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1021\/bi015662v","article-title":"Diverse stability and catalytic properties of human tryptase alpha and beta isoforms are mediated by residue differences at the S1 pocket","volume":"41","author":"Selwood","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.jaip.2021.03.005_bib43","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1084\/jem.20190701","article-title":"Impact of naturally forming human alpha\/beta-tryptase heterotetramers in the pathogenesis of hereditary alpha-tryptasemia","volume":"216","author":"Le","year":"2019","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaip.2021.03.005_bib44","first-page":"1910","article-title":"The epidemiology of irritable bowel syndrome in North America: a systematic review","volume":"97","author":"Saito","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaip.2021.03.005_bib45","first-page":"804","article-title":"Epidemiology of general joint hypermobility and basis for the proposed criteria for benign joint hypermobility syndrome: review of the literature","volume":"34","author":"Remvig","year":"2007","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.jaip.2021.03.005_bib46","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jaci.2005.12.1303","article-title":"Second symposium on the definition and management of anaphylaxis: summary report\u2014Second National Institute of Allergy and Infectious Disease\/Food Allergy and Anaphylaxis Network symposium","volume":"117","author":"Sampson","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.03.005_bib47","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.iac.2018.04.004","article-title":"Association of postural tachycardia syndrome and Ehlers-Danlos syndrome with mast cell activation disorders","volume":"38","author":"Bonamichi-Santos","year":"2018","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2021.03.005_bib48","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1182\/blood-2016-09-731893","article-title":"2016 updated WHO classification and novel emerging treatment concepts","volume":"11","author":"Valent","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2021.03.005_bib49","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s10875-018-0506-y","article-title":"First identification of an inherited TPSAB1 quintuplication in a patient with clonal mast cell disease","volume":"38","author":"Sabato","year":"2018","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2021.03.005_bib50","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1016\/j.jaip.2020.01.012","article-title":"Usefulness of testing for hereditary alpha tryptasemia in symptomatic patients with elevated tryptase","volume":"8","author":"Carrigan","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.03.005_bib51","doi-asserted-by":"crossref","first-page":"404","DOI":"10.2500\/aap.2014.35.3769","article-title":"Serum basal tryptase levels in healthy children: correlation between age and gender","volume":"35","author":"Sahiner","year":"2014","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2021.03.005_bib52","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/ajd.12146","article-title":"Disease spectrum in patients with elevated serum tryptase levels","volume":"56","author":"Aberer","year":"2015","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.jaip.2021.03.005_bib53","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.molimm.2014.04.001","article-title":"Human mast cell tryptase in biology and medicine","volume":"63","author":"Vitte","year":"2015","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jaip.2021.03.005_bib54","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1365-2222.2009.03436.x","article-title":"Serum concentration of baseline mast cell tryptase: evidence for a decline during long-term immunotherapy for Hymenoptera venom allergy","volume":"40","author":"Dugas-Breit","year":"2010","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2021.03.005_bib55","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/j.jaci.2013.10.046","article-title":"Sensitization to Hymenoptera venoms is common, but systemic sting reactions are rare","volume":"133","author":"Sturm","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.03.005_bib56","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.anai.2019.09.026","article-title":"Clinical response to omalizumab in patients with hereditary \u03b1-tryptasemia","volume":"124","author":"Mendoza Alvarez","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2021.03.005_bib57","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000501637","article-title":"AK002, a humanized sialic acid-binding immunoglobulin-like lectin-8 antibody that induces antibody-dependent cell-mediated cytotoxicity against human eosinophils and inhibits mast cell-mediated anaphylaxis in mice","volume":"180","author":"Youngblood","year":"2019","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2021.03.005_bib58","doi-asserted-by":"crossref","first-page":"e131347","DOI":"10.1172\/jci.insight.131347","article-title":"Phase 2a randomized, placebo-controlled study of anti-IL-33 in peanut allergy","volume":"4","author":"Chinthrajah","year":"2019","journal-title":"JCI Insight"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219821003068?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219821003068?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:27:40Z","timestamp":1761974860000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219821003068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":58,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S2213219821003068"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2021.03.005","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Genetic Basis and Clinical Impact of Hereditary Alpha-Tryptasemia","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2021.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}